Cargando…
Liposomal Irinotecan: A Review in Metastatic Pancreatic Adenocarcinoma
Liposomal irinotecan (nal-IRI; Onivyde(®); also known as pegylated liposomal irinotecan) has been developed with the aim of maximising anti-tumour efficacy while minimising drug-related toxicities compared with the conventional (non-liposomal) formulation of this topoisomerase 1 inhibitor. In combin...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347682/ https://www.ncbi.nlm.nih.gov/pubmed/32557396 http://dx.doi.org/10.1007/s40265-020-01336-6 |